Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Optimal glycaemic control associated with lower pancreatic cancer risk in T2D
Optimal glycaemic control associated with lower pancreatic cancer risk in T2D
19 Sep 2025 bởiChristina Lau

In patients with type 2 diabetes (T2D), optimal glycaemic control is associated with lower risks of pancreatic cancer as well as pancreatic cancer–related mortality and all-cause mortality, a territory-wide population-based retrospective cohort study has shown.

Optimal glycaemic control associated with lower pancreatic cancer risk in T2D
19 Sep 2025
Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity
Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity
17 Sep 2025 bởiStephen Padilla

Patients with heart failure (HF) with preserved ejection fraction (HFpEF), obesity, and type 2 diabetes (T2D) show a favourable response to tirzepatide despite less pronounced weight loss, reports a study.

Diabetes does not influence effects of tirzepatide in HFpEF patients with obesity
17 Sep 2025